Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

NCT03863119 · clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Santhera Pharmaceuticals